Dustin Marks
Dermatology · New York, NYNPI 1497379184
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,463 of the $5,625 with a category attached, or 79.4%. 26 manufacturers reported payments, led by AbbVie at 45.1% of the total. 2025 is the largest year on record at $2,542, more than ten times the $92 reported in 2021.
Across 123 payments — averaging $45.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Johnson & Johnson$499
- Revance Therapeutics, Inc.$316
- Galderma Laboratories, L.p.$255
- E.r. Squibb & Sons, L.L.C.$240
- Merz North America, Inc.$179
- plus $2K from 20 others
What the payments were for
- Travel & lodging$90216%
- Food & beverage$4,46379%
- Education$2595%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 37 | $2,538 |
| Johnson & Johnson | 19 | $499 |
| Revance Therapeutics, Inc. | 1 | $316 |
| Galderma Laboratories, L.p. | 14 | $255 |
| E.r. Squibb & Sons, L.L.C. | 2 | $240 |
| Merz North America, Inc. | 1 | $179 |
| Incyte Corporation | 6 | $157 |
| Regeneron Healthcare Solutions, Inc. | 2 | $154 |
| Pfizer | 5 | $140 |
| Almirall LLC | 6 | $138 |
| Boehringer Ingelheim | 1 | $125 |
| Novartis | 4 | $111 |
| UCB, Inc. | 4 | $105 |
| Lilly USA, LLC | 4 | $94 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Mayne Pharma Commercial LLC | 3 | $74 |
| Sanofi | 2 | $68 |
| Janssen Scientific Affairs, LLC | 1 | $60 |
| Amgen | 2 | $54 |
| Sun Pharmaceutical Industries Inc. | 2 | $49 |
| Cipher Pharmaceuticals US LLC | 1 | $49 |
| Verrica Pharmaceuticals Inc. | 1 | $38 |
| Journey Medical Corporation | 1 | $27 |
| Organon | 1 | $27 |
| LEO Pharma Inc. | 1 | $26 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,625 in reported general payments places this provider in the 65th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Triamcinolone Acetonide | 25 | $694 |
| Fluorouracil | 12 | $521 |
| Ketoconazole | 11 | $144 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.